IFNA1 and neoplasm: Here, we describe a lentiviral vector (LV)-based gene therapy approach to enforce coordinated expression of tumor antigens (TAs), IFNα, and IL-12 selectively in liver and tumor-associated macrophages (TAMs) after single intravenous administration.